Home/Filings/4/0001144204-18-034792
4//SEC Filing

McNaughton Thomas 4

Accession 0001144204-18-034792

CIK 0001563665other

Filed

Jun 18, 8:00 PM ET

Accepted

Jun 19, 4:15 PM ET

Size

4.7 KB

Accession

0001144204-18-034792

Insider Transaction Report

Form 4
Period: 2018-06-15
McNaughton Thomas
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2018-06-15$4.40/sh+2,500$11,00013,734 total

Issuer

Biostage, Inc.

CIK 0001563665

Entity typeother

Related Parties

1
  • filerCIK 0001449450

Filing Metadata

Form type
4
Filed
Jun 18, 8:00 PM ET
Accepted
Jun 19, 4:15 PM ET
Size
4.7 KB